{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:29:48Z","timestamp":1762208988554,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["3P30CA021765","1R01CA229739\\u201301","R01CA266600","5K08CA255569\\u2013"],"award-info":[{"award-number":["3P30CA021765","1R01CA229739\\u201301","R01CA266600","5K08CA255569\\u2013"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007737","name":"St. Jude Children&apos;s Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jpedsurg.2024.162122","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T11:12:08Z","timestamp":1735211528000},"page":"162122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts\u2606"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4629-7615","authenticated-orcid":false,"given":"Daniel B.","family":"Gehle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7122-0180","authenticated-orcid":false,"given":"Carolyn M.","family":"Jablonowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prahalathan","family":"Pichavaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary A.","family":"Woolard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4027-7050","authenticated-orcid":false,"given":"Christopher L.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-4946","authenticated-orcid":false,"given":"Catherine A.","family":"Billups","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7900-2794","authenticated-orcid":false,"given":"Andrew M.","family":"Davidoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-3220","authenticated-orcid":false,"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-0355","authenticated-orcid":false,"given":"Andrew J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpedsurg.2024.162122_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mpo.2950210305","article-title":"Epidemiology of Wilms tumor","volume":"21","author":"Breslow","year":"1993","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"10.1016\/j.jpedsurg.2024.162122_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","article-title":"International incidence of childhood cancer, 2001-10: a population-based registry study","volume":"18","author":"Steliarova-Foucher","year":"2017","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-021-00308-8","article-title":"Wilms tumour","volume":"7","author":"Spreafico","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"15","key":"10.1016\/j.jpedsurg.2024.162122_bib4","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.2005.04.7852","article-title":"Treatment of anaplastic histology Wilms' tumor: results from the fifth national Wilms' tumor study","volume":"24","author":"Dome","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.jpedsurg.2024.162122_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pbc.20822","article-title":"Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group","volume":"48","author":"Green","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.jpedsurg.2024.162122_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pbc.21267","article-title":"Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group","volume":"50","author":"Malogolowkin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"10.1016\/j.jpedsurg.2024.162122_bib7","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.01265","article-title":"Activity of vincristine and irinotecan in diffuse anaplastic Wilms tumor and therapy outcomes of stage II to IV disease: results of the Children's Oncology group AREN0321 study","volume":"38","author":"Daw","year":"2020","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.jpedsurg.2024.162122_bib8","article-title":"Advances in the clinical management of high-risk Wilms tumors","volume":"70","author":"Ortiz","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.jpedsurg.2024.162122_bib9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/pbc.25131","article-title":"Orthotopic Wilms tumor xenografts derived from cell lines reflect limited aspects of tumor morphology and clinical characteristics","volume":"61","author":"Mengelbier","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib10","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1038\/s41467-019-13646-9","article-title":"Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor","volume":"10","author":"Murphy","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","article-title":"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity","volume":"11","author":"Calandrini","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jpedsurg.2024.162122_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41388-019-1027-8","article-title":"High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro","volume":"39","author":"Wegert","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib13","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1038\/s41598-021-83809-6","article-title":"3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination","volume":"11","author":"Roper","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpedsurg.2024.162122_bib14","article-title":"Patient-derived models: advanced tools for precision medicine in neuroblastoma","volume":"12","author":"Aaltonen","year":"2022","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.jpedsurg.2024.162122_bib15","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.3390\/ijms20235836","article-title":"Telomere maintenance in pediatric cancer","volume":"20","author":"Ackermann","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jpedsurg.2024.162122_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/jnci\/djz210","article-title":"Molecular mechanism of telomere length dynamics and its prognostic value in pediatric cancers","volume":"112","author":"Wang","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.162122_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","article-title":"Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies","volume":"8","author":"Jafri","year":"2016","journal-title":"Genome Med"},{"issue":"24","key":"10.1016\/j.jpedsurg.2024.162122_bib19","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1158\/1078-0432.CCR-21-0374","article-title":"A modified nucleoside 6-thio-2\u2019-deoxyguanosine exhibits anti-tumor activity in gliomas","volume":"27","author":"Yu","year":"2021","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res."},{"issue":"19","key":"10.1016\/j.jpedsurg.2024.162122_bib20","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1158\/1078-0432.CCR-17-2773","article-title":"Induction of telomere dysfunction prolongs disease control of therapy-resistant melanoma","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res."},{"issue":"6","key":"10.1016\/j.jpedsurg.2024.162122_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1535-7163.MCT-23-0039","article-title":"Activating an adaptive immune response with a telomerase-mediated telomere targeting therapeutic in hepatocellular carcinoma","volume":"22","author":"Mender","year":"2023","journal-title":"Mol Cancer Therapeut"},{"issue":"5","key":"10.1016\/j.jpedsurg.2024.162122_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s13402-022-00702-8","article-title":"Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models","volume":"45","author":"Fischer-Mertens","year":"2022","journal-title":"Cell Oncol Dordr Neth"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41467-024-44861-8","article-title":"A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer","volume":"15","author":"Eglenen-Polat","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jpedsurg.2024.162122_bib24","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41418-023-01149-6","article-title":"Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts","volume":"30","author":"Pi\u00f1eiro-Hermida","year":"2023","journal-title":"Cell Death Differ"},{"issue":"7","key":"10.1016\/j.jpedsurg.2024.162122_bib25","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3390\/cancers14071655","article-title":"TERT expression in Wilms tumor is regulated by promoter mutation or hypermethylation, WT1, and N-MYC","volume":"14","author":"Jablonowski","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.jpedsurg.2024.162122_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0046-8177(98)90072-7","article-title":"Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis","volume":"29","author":"Yashima","year":"1998","journal-title":"Hum Pathol"},{"issue":"36","key":"10.1016\/j.jpedsurg.2024.162122_bib27","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1200\/JCO.2005.00.562","article-title":"High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor","volume":"23","author":"Dome","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"17","key":"10.1016\/j.jpedsurg.2024.162122_bib28","first-page":"4301","article-title":"High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor","volume":"59","author":"Dome","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jpedsurg.2024.162122_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s13277-011-0178-1","article-title":"Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor","volume":"32","author":"Diniz","year":"2011","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"issue":"6","key":"10.1016\/j.jpedsurg.2024.162122_bib30","article-title":"Genetic changes associated with relapse in favorable histology Wilms tumor: a Children's Oncology Group AREN03B2 study","volume":"3","author":"Gadd","year":"2022","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.162122_bib31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ijc.11429","article-title":"Derivation and characterization of a Wilms' tumour cell line, WiT 49","volume":"107","author":"Alami","year":"2003","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.101079","article-title":"Normal and tumor-derived organoids as a drug screening platform for tumor-specific drug vulnerabilities","volume":"3","author":"Calandrini","year":"2022","journal-title":"STAR Protoc."},{"issue":"2","key":"10.1016\/j.jpedsurg.2024.162122_bib33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nprot.2007.25","article-title":"Establishment of human tumor xenografts in immunodeficient mice","volume":"2","author":"Morton","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jpedsurg.2024.162122_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1408s39","article-title":"Preclinical chemotherapeutic tumor models of common childhood cancers: solid tumors, acute lymphoblastic leukemia, and disseminated neuroblastoma","author":"Morton","year":"2007","journal-title":"Curr Protoc Pharmacol"},{"issue":"7","key":"10.1016\/j.jpedsurg.2024.162122_bib35","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/pbc.21078","article-title":"The pediatric preclinical testing program: description of models and early testing results","volume":"49","author":"Houghton","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jpedsurg.2024.162122_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin\u2014an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.jpedsurg.2024.162122_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109924","article-title":"TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia","volume":"9","author":"Maschietto","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib38","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1038\/s41467-023-43290-3","article-title":"Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors","volume":"14","author":"Su","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib39","article-title":"A gradual transition toward anaplasia in Wilms tumor through tolerance to genetic damage","volume":"37","author":"Uno","year":"2024","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc."},{"issue":"22","key":"10.1016\/j.jpedsurg.2024.162122_bib40","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1158\/1078-0432.CCR-16-0985","article-title":"Significance of TP53 mutation in Wilms tumors with diffuse anaplasia: a report from the Children's Oncology group","volume":"22","author":"Ooms","year":"2016","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"4","key":"10.1016\/j.jpedsurg.2024.162122_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/cjp2.77","article-title":"TP53 alterations in Wilms tumour represent progression events with strong intratumour heterogeneity that are closely linked but not limited to anaplasia","volume":"3","author":"Wegert","year":"2017","journal-title":"J Pathol Clin Res"},{"issue":"5","key":"10.1016\/j.jpedsurg.2024.162122_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.embor.7400937","article-title":"Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence","volume":"8","author":"Cosme-Blanco","year":"2007","journal-title":"EMBO Rep"},{"issue":"6963","key":"10.1016\/j.jpedsurg.2024.162122_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"d'Adda di Fagagna","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpedsurg.2024.162122_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/2159-8290.CD-14-0609","article-title":"Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2\u2019-deoxyguanosine","volume":"5","author":"Mender","year":"2015","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.jpedsurg.2024.162122_bib45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1158\/0008-5472.CAN-19-2257","article-title":"SLC43A3 is a biomarker of sensitivity to the telomeric DNA damage mediator 6-thio-2\u2019-deoxyguanosine","volume":"80","author":"Mender","year":"2020","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.jpedsurg.2024.162122_bib46","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ccell.2020.05.020","article-title":"Telomere stress potentiates STING-dependent anti-tumor immunity","volume":"38","author":"Mender","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346824010844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346824010844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:28:07Z","timestamp":1762208887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346824010844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0022346824010844"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2024.162122","relation":{},"ISSN":["0022-3468"],"issn-type":[{"type":"print","value":"0022-3468"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts\u2606","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2024.162122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"162122"}}